ArticleScientific reports2019

SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.

Katharina Ehrenhöfer-Wölfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.